Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Association between marijuana exposure and pulmonary function over 20 years.

Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Safford M, Sidney S, Lin F, Kertesz S.

JAMA. 2012 Jan 11;307(2):173-81. doi: 10.1001/jama.2011.1961.

2.

The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study.

Kempker JA, Honig EG, Martin GS.

Ann Am Thorac Soc. 2015 Feb;12(2):135-41. doi: 10.1513/AnnalsATS.201407-333OC.

3.

Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Auer R, Vittinghoff E, Yaffe K, Künzi A, Kertesz SG, Levine DA, Albanese E, Whitmer RA, Jacobs DR Jr, Sidney S, Glymour MM, Pletcher MJ.

JAMA Intern Med. 2016 Mar;176(3):352-61. doi: 10.1001/jamainternmed.2015.7841.

4.

Lung function and exposure to workplace second-hand smoke during exemptions from smoking ban legislation: an exposure-response relationship based on indoor PM2.5 and urinary cotinine levels.

Lai HK, Hedley AJ, Repace J, So C, Lu QY, McGhee SM, Fielding R, Wong CM.

Thorax. 2011 Jul;66(7):615-23. doi: 10.1136/thx.2011.160291. Epub 2011 May 6.

PMID:
21551212
5.

A matter of life and breath: childhood socioeconomic status is related to young adult pulmonary function in the CARDIA study.

Jackson B, Kubzansky LD, Cohen S, Weiss S, Wright RJ; CARDIA Study.

Int J Epidemiol. 2004 Apr;33(2):271-8.

PMID:
15082626
6.

The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study.

Rodriguez J, Jiang R, Johnson WC, MacKenzie BA, Smith LJ, Barr RG.

Ann Intern Med. 2010 Feb 16;152(4):201-10. doi: 10.7326/0003-4819-152-4-201002160-00004.

7.

Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury.

Jain NB, Brown R, Tun CG, Gagnon D, Garshick E.

Arch Phys Med Rehabil. 2006 Oct;87(10):1327-33.

8.

Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study.

Söderholm M, Zia E, Hedblad B, Engström G.

Stroke. 2012 Oct;43(10):2598-603. Epub 2012 Aug 7.

10.

Systemic inflammation in young adults is associated with abnormal lung function in middle age.

Kalhan R, Tran BT, Colangelo LA, Rosenberg SR, Liu K, Thyagarajan B, Jacobs DR Jr, Smith LJ.

PLoS One. 2010 Jul 2;5(7):e11431. doi: 10.1371/journal.pone.0011431. Erratum in: PLoS One. 2010;5(8). doi 10.1371/annotation/ed92662b-c566-488d-b090-6c80046d3499..

11.

Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function.

Tang W, Bentley AR, Kritchevsky SB, Harris TB, Newman AB, Bauer DC, Meibohm B, Cassano PA; Health ABC study.

Free Radic Biol Med. 2013 Oct;63:304-12. doi: 10.1016/j.freeradbiomed.2013.05.016. Epub 2013 May 17.

13.

Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States.

Papatheodorou SI, Buettner H, Rice MB, Mittleman MA.

Chest. 2016 Jun;149(6):1428-35. doi: 10.1016/j.chest.2015.12.033. Epub 2016 Jan 16.

14.

Respiratory effects of non-tobacco cigarettes.

Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD.

Br Med J (Clin Res Ed). 1987 Dec 12;295(6612):1516-8.

15.

Plasma fibrinogen and lung function: the CARDIA Study.

Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD.

Int J Epidemiol. 2006 Aug;35(4):1001-8. Epub 2006 Mar 22.

PMID:
16554379
16.

Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.

Masuko H, Sakamoto T, Kaneko Y, Iijima H, Naito T, Noguchi E, Hirota T, Tamari M, Hizawa N.

Int J Chron Obstruct Pulmon Dis. 2011;6:181-9. doi: 10.2147/COPD.S16383. Epub 2011 Mar 2.

17.

Serum carotenoid concentrations predict lung function evolution in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Thyagarajan B, A Meyer K, Smith LJ, Beckett WS, Williams OD, Gross MD, Jacobs DR Jr.

Am J Clin Nutr. 2011 Nov;94(5):1211-8. doi: 10.3945/ajcn.111.019067. Epub 2011 Sep 14.

18.

IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function.

Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, Ohar JA.

Am J Respir Crit Care Med. 2007 Oct 15;176(8):748-52. Epub 2007 Jul 5.

PMID:
17615386
19.

Early life origins of chronic obstructive pulmonary disease.

Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norbäck D, Raherison C, Villani S, Wjst M, Svanes K, Antó JM.

Thorax. 2010 Jan;65(1):14-20. doi: 10.1136/thx.2008.112136. Epub 2009 Sep 2.

PMID:
19729360
20.

Supplemental Content

Support Center